Mehra Uneek
Insider CIK 1881504 · FDMT See Remarks · MYOV Principal Financial Officer · BBOT Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BBOT BridgeBio Oncology Therape | F Tax w/h | 2026-04-01 | 2026-05-05 | 524 | $9.03 | $4.7K | 22,806 | SEC↗ |
| BBOT BridgeBio Oncology Therape | A Award deriv | 2026-03-10 | 2026-03-12 | 105,000 | — | $0 | 105,000 | SEC↗ |
| BBOT BridgeBio Oncology Therape | A Award | 2026-03-10 | 2026-03-12 | 23,330 | — | $0 | 23,330 | SEC↗ |
| BBOT BridgeBio Oncology Therape | A Award deriv | 2025-08-26 | 2025-08-28 | 633,570 | — | $0 | 633,570 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | A Award deriv | 2025-03-06 | 2025-03-10 | 130,000 | — | $0 | 130,000 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | A Award deriv | 2023-12-11 | 2023-12-13 | 75,000 | — | $0 | 75,000 | SEC↗ |
| FMDT 4D Molecular Therapeutics, | A Award deriv | 2023-10-01 | 2023-10-03 | 229,634 | — | $0 | 229,634 | SEC↗ |
| MYOV Myovant Sciences Ltd. | D To issuer deriv | 2023-03-10 | 2023-03-10 | 111,111 | — | $0 | 0 | SEC↗ |
| MYOV Myovant Sciences Ltd. | D To issuer deriv | 2023-03-10 | 2023-03-10 | 165,192 | — | $0 | 0 | SEC↗ |
| MYOV Myovant Sciences Ltd. | D To issuer | 2023-03-10 | 2023-03-10 | 181,972 | — | $0 | 0 | SEC↗ |
| MYOV Myovant Sciences Ltd. | D To issuer | 2023-03-10 | 2023-03-10 | 20,724 | — | $0 | 181,972 | SEC↗ |
| MYOV Myovant Sciences Ltd. | S Sale | 2022-12-16 | 2022-12-20 | 2,241 | $26.75 | $59.9K | 202,696 | SEC↗ |
| MYOV Myovant Sciences Ltd. | S Sale | 2022-09-16 | 2022-09-20 | 9,243 | $18.86 | $174.3K | 204,937 | SEC↗ |
| MYOV Myovant Sciences Ltd. | A Award | 2022-04-15 | 2022-04-19 | 111,111 | — | $0 | 214,180 | SEC↗ |
| MYOV Myovant Sciences Ltd. | A Award deriv | 2021-09-15 | 2021-09-17 | 165,192 | — | $0 | 165,192 | SEC↗ |
| MYOV Myovant Sciences Ltd. | A Award | 2021-09-15 | 2021-09-17 | 103,069 | — | $0 | 103,069 | SEC↗ |